Spotify Aims for 1 Billion Paid Users Amid Artist Payout Criticism
Spotify has set an ambitious goal to reach 1 billion paid subscribers, doubling its current 500 million user base across all platforms. The company believes that streaming services have contributed to normalizing paid music, benefiting artists and creating a more sustainable music ecosystem.
In a recent announcement, Spotify revealed that it paid a total of $10 billion to the music industry in 2024. This brings the platform’s total contributions to nearly $60 billion since its inception in 2006. The company claims that this growth has had a positive impact on artist earnings, with over 10,000 musicians now earning more than $100,000 annually—ten times the number of such musicians in 2014.
However, despite this success, Spotify continues to face criticism from artists regarding per-stream payouts. Many musicians argue that the platform offers lower compensation compared to competitors like Apple Music and YouTube Music. Furthermore, emerging artists feel that Spotify’s algorithm favours mainstream acts, making it more difficult for lesser-known musicians to gain exposure.
In defense of its model, Spotify’s Chris Macowski explained that while its per-stream rates are lower, this is balanced by a higher overall engagement. According to Macowski, the company prioritizes maximizing total payouts to the music industry rather than focusing on individual per-stream compensation.
Spotify’s efforts are paying off financially, with the company reporting a 19% revenue increase in the last quarter and forecasting its first full year of profitability. Nevertheless, tensions remain, particularly after Spotify took legal action against a parody website that criticized the disparity between user subscription fees and artist royalties.
As Spotify works toward its goal of 1 billion paid users, the conversation around artist payouts and platform fairness is likely to continue, challenging the streaming giant to balance growth with equitable compensation for its contributors.